Historic Total Non-Current Liabilities for Nuvation Bio (NUVB) over the last 4 years, with Jun 2025 value amounting to $272.0 million.
- Nuvation Bio's Total Non-Current Liabilities rose 344.22% to $272.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $471.4 million, marking a year-over-year increase of 317.17%. This contributed to the annual value of $74.8 million for FY2024, which is 367.14% up from last year.
- According to the latest figures from Q2 2025, Nuvation Bio's Total Non-Current Liabilities is $272.0 million, which was up 287.28% from $70.2 million recorded in Q1 2025.
- In the past 5 years, Nuvation Bio's Total Non-Current Liabilities ranged from a high of $272.0 million in Q2 2025 and a low of $10.2 million during Q1 2021.
- Over the past 3 years, Nuvation Bio's median Total Non-Current Liabilities value was $40.0 million (recorded in 2023), while the average stood at $67.3 million.
- Per our database at Business Quant, Nuvation Bio's Total Non-Current Liabilities crashed by 36.84% in 2023 and then skyrocketed by 344.22% in 2025.
- Nuvation Bio's Total Non-Current Liabilities (Quarterly) stood at $13.5 million in 2021, then increased by 28.87% to $17.4 million in 2022, then climbed by 7.53% to $18.7 million in 2023, then soared by 263.56% to $68.0 million in 2024, then surged by 344.22% to $272.0 million in 2025.
- Its Total Non-Current Liabilities was $272.0 million in Q2 2025, compared to $70.2 million in Q1 2025 and $68.0 million in Q3 2024.
